AU631204B2 - Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs - Google Patents
Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugsInfo
- Publication number
- AU631204B2 AU631204B2 AU54030/90A AU5403090A AU631204B2 AU 631204 B2 AU631204 B2 AU 631204B2 AU 54030/90 A AU54030/90 A AU 54030/90A AU 5403090 A AU5403090 A AU 5403090A AU 631204 B2 AU631204 B2 AU 631204B2
- Authority
- AU
- Australia
- Prior art keywords
- composition
- monoacyl
- lysolecithin
- phosphoglyceride
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US329924 | 1988-03-29 | ||
US32992489A | 1989-03-29 | 1989-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5403090A AU5403090A (en) | 1990-10-22 |
AU631204B2 true AU631204B2 (en) | 1992-11-19 |
Family
ID=23287604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54030/90A Expired - Fee Related AU631204B2 (en) | 1989-03-29 | 1990-03-28 | Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0465580A4 (xx) |
JP (1) | JPH04504258A (xx) |
AU (1) | AU631204B2 (xx) |
CA (1) | CA2013225A1 (xx) |
IL (1) | IL93925A0 (xx) |
WO (1) | WO1990011079A1 (xx) |
ZA (1) | ZA902442B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5109118A (en) * | 1989-07-06 | 1992-04-28 | Yutaka Mizushima | Modified biologically active proteins |
FR2673513B1 (fr) * | 1991-03-05 | 1993-10-29 | Institut Recherche Biologique Sa | Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision. |
WO1999009037A1 (de) | 1997-08-18 | 1999-02-25 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Phospholipidanaloge verbindungen |
EP2574341B1 (en) | 2004-03-29 | 2017-03-29 | University Of South Florida | Effective treatment of tumors and cancer with triciribine phosphate |
JP5670200B2 (ja) * | 2008-12-02 | 2015-02-18 | ロート製薬株式会社 | 眼科用組成物 |
US12042500B2 (en) * | 2018-04-03 | 2024-07-23 | Hyderabad Eye Research Foundation | Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62270521A (ja) * | 1986-05-16 | 1987-11-24 | Green Cross Corp:The | フルルビプロフエン眼投与製剤 |
GB8712176D0 (en) * | 1987-05-22 | 1987-06-24 | Cosmas Damian Ltd | Drug delivery system |
-
1990
- 1990-03-28 WO PCT/US1990/001584 patent/WO1990011079A1/en not_active Application Discontinuation
- 1990-03-28 EP EP19900906019 patent/EP0465580A4/en not_active Withdrawn
- 1990-03-28 AU AU54030/90A patent/AU631204B2/en not_active Expired - Fee Related
- 1990-03-28 CA CA002013225A patent/CA2013225A1/en not_active Abandoned
- 1990-03-28 JP JP2505708A patent/JPH04504258A/ja active Pending
- 1990-03-28 IL IL93925A patent/IL93925A0/xx unknown
- 1990-03-29 ZA ZA902442A patent/ZA902442B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL93925A0 (en) | 1990-12-23 |
ZA902442B (en) | 1991-01-30 |
JPH04504258A (ja) | 1992-07-30 |
EP0465580A1 (en) | 1992-01-15 |
CA2013225A1 (en) | 1990-09-29 |
AU5403090A (en) | 1990-10-22 |
EP0465580A4 (en) | 1992-03-18 |
WO1990011079A1 (en) | 1990-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5221696A (en) | Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs | |
EP0845268B1 (en) | Use of SCF for treating cornea | |
CA2423354C (en) | Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications | |
EP1553953B1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
US5283236A (en) | Systemic delivery of polypeptides through the eye | |
US6630135B1 (en) | Use of sustained release antibiotic compositions in ophthalmic surgical procedures | |
US20190070176A1 (en) | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | |
US20030185892A1 (en) | Intraocular delivery compositions and methods | |
US20120264681A1 (en) | Buffered ophthalmic compositions and methods of use thereof | |
KR101560429B1 (ko) | 눈의 통증을 치료 또는 예방하기 위한 케토롤락 트로메타민 조성물 | |
SK119895A3 (en) | Pharmaceutical composition containing lipophilic drugs | |
US5278142A (en) | Systemic delivery of polypeptides through the eye | |
Phinney et al. | Corneal edema related to accidental Hibiclens exposure | |
JPH0723325B2 (ja) | 眼病用製剤 | |
AU631204B2 (en) | Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs | |
EP0655911B1 (en) | Ophthalmological preparation | |
EP0444778A1 (en) | Use of alkyl saccharides to enhance the penetration of drugs | |
JPH03133936A (ja) | 蛋白質ゲル状眼用賦形剤 | |
JPH08503969A (ja) | 増殖因子と組織形成抑制剤を含有する組成物 | |
Palmer et al. | Tear film, pharmacology of eye drops, and toxicity | |
US20210128458A1 (en) | Ophthalmic compositions containing a nitric oxide releasing prostamide | |
WO1999022715A1 (en) | Sustained release eyedrops | |
CZ294314B6 (cs) | Topické oftalmické léčivo | |
RU2434633C2 (ru) | Фармацевтические препаративные формы латрункулина | |
WO2006043172A1 (en) | Pharmaceutical compositions and methods for sub-tenon delivery |